These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12559647)

  • 21. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The eye in AIDS.
    Lightman S; Towler HM
    Br J Hosp Med; 1996 Feb 7-20; 55(3):95-99. PubMed ID: 8907870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent.
    Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E
    Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
    Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group.
    Am J Ophthalmol; 2001 Apr; 131(4):457-67. PubMed ID: 11292409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus retinitis.
    Harooni M; Lashkari K; Freilich JM; Schepens CL
    Int Ophthalmol Clin; 1996; 36(3):131-40. PubMed ID: 8989605
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical issues related to early closure of STOP-ROP, a group-sequential trial.
    Oden NL; Phelps DL;
    Control Clin Trials; 2003 Feb; 24(1):28-38. PubMed ID: 12559640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmic manifestations of HIV: an update.
    DeGrezia MG; Robinson M
    J Assoc Nurses AIDS Care; 2001; 12(3):22-32. PubMed ID: 11387803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases.
    Ellenberg SS; Myers MW; Blackwelder WC; Hoth DF
    Stat Med; 1993 Mar; 12(5-6):461-7; discussion 469. PubMed ID: 8493424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CMV retinitis--"the lightning that announces a storm"].
    Gafencu O; Cârstocea B; Ioniţă M
    Oftalmologia; 1998; 45(4):14-20. PubMed ID: 10418623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retinal manifestations of AIDS].
    Cassoux N; Reux I; Guex-Crosier Y; LeHoang P
    Rev Prat; 1996 Sep; 46(14):1745-9. PubMed ID: 8949282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is cytomegalovirus viraemia a useful tool in managing CMV disease?
    Deayton JR
    Sex Transm Infect; 2000 Oct; 76(5):342-4. PubMed ID: 11141848
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S; Birthistle K; Dalton R; Hay PE
    Lancet; 1997 Aug; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract]   [Full Text] [Related]  

  • 36. [Present status and advances in pharmacotherapy for cytomegalovirus retinitis associated with acquired immunodeficiency syndrome].
    Wang WW; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1148-52. PubMed ID: 21211231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmology: the role of the non-specialist.
    Davey CC
    Br J Hosp Med; 1996 Feb 7-20; 55(3):84. PubMed ID: 8907867
    [No Abstract]   [Full Text] [Related]  

  • 38. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
    Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytomegalovirus retinitis in HIV positive patients].
    Anghel G
    Oftalmologia; 2002; 55(4):25-9. PubMed ID: 12723173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.